| Symbol |
Name |
Standardized Value |
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2
|
1.1507
|
|
JUND
|
jun D proto-oncogene
|
1.1507
|
|
ITIH3
|
inter-alpha-trypsin inhibitor heavy chain 3
|
1.1507
|
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1
|
1.1507
|
|
GFRA2
|
GDNF family receptor alpha 2
|
1.1507
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
0.575348
|
|
TBC1D1
|
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1
|
0.575348
|
|
NFIB
|
nuclear factor I/B
|
0.479456
|
|
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10
|
0.431511
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
0.383565
|
|
AOC1
|
amine oxidase, copper containing 1
|
0.287674
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
0.287674
|
|
HNMT
|
histamine N-methyltransferase
|
0.230139
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
0.230139
|
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
0.230139
|
|
C3
|
complement component 3
|
0.191783
|
|
PRKAB2
|
protein kinase, AMP-activated, beta 2 non-catalytic subunit
|
0.191783
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
0.164385
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
0.164385
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
0.143837
|
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18
|
0.143837
|
|
GSTT1
|
glutathione S-transferase theta 1
|
0.127855
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
0.127855
|
|
SH2B1
|
SH2B adaptor protein 1
|
0.11507
|
|
RABEP1
|
rabaptin, RAB GTPase binding effector protein 1
|
0.104609
|
|
GDNF
|
glial cell derived neurotrophic factor
|
0.104609
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
0.0958913
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
0.0908444
|
|
FKBP5
|
FK506 binding protein 5
|
0.088515
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
0.088515
|
|
CYP3A43
|
cytochrome P450, family 3, subfamily A, polypeptide 43
|
0.0821925
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
0.0719185
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
0.067688
|
|
MC4R
|
melanocortin 4 receptor
|
0.0621998
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
0.0605629
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
0.058709
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
0.0523043
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
0.050766
|
|
GSTM1
|
glutathione S-transferase mu 1
|
0.0500302
|
|
LEP
|
leptin
|
0.0479456
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
0.0460278
|
|
FAAH
|
fatty acid amide hydrolase
|
0.0454222
|
|
FASN
|
fatty acid synthase
|
0.0426183
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
0.0410963
|
|
GCG
|
glucagon
|
0.0410963
|
|
HRH4
|
histamine receptor H4
|
0.0401405
|
|
HTR7
|
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
|
0.0373602
|
|
DRD4
|
dopamine receptor D4
|
0.0364144
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
0.033844
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
0.0263921
|
|
CCKBR
|
cholecystokinin B receptor
|
0.0250151
|
|
HTR5A
|
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled
|
0.0230139
|
|
DRD2
|
dopamine receptor D2
|
0.0207333
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
0.0195033
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
0.0179796
|
|
IL2
|
interleukin 2
|
0.017703
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
0.017703
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
0.0171234
|
|
PRL
|
prolactin
|
0.0164385
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
0.0155499
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
0.0151407
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
0.0146275
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
0.0145658
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
0.0145658
|
|
TACR1
|
tachykinin receptor 1
|
0.0143837
|
|
DRD5
|
dopamine receptor D5
|
0.0136988
|
|
DRD1
|
dopamine receptor D1
|
0.012645
|
|
HTR1F
|
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled
|
0.0125076
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
0.0119037
|
|
HTR1E
|
5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled
|
0.0112813
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
0.00938067
|
|
HRH1
|
histamine receptor H1
|
0.00894323
|
|
HTR6
|
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
|
0.00810349
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
0.00618653
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
0.00593142
|
|
HTR1D
|
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
|
0.00564066
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
0.0054795
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
0.00537708
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
0.00537708
|
|
DRD3
|
dopamine receptor D3
|
0.0049175
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
0.00487583
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
0.00413919
|
|
CBX1
|
chromobox homolog 1
|
0.00306036
|
|
POLI
|
polymerase (DNA directed) iota
|
0.00268854
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
0.00263921
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
0.00259751
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
0.00241236
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
0.00197037
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
9.41649E-4
|